title: Drug-resistant tuberculosis in high-risk groups, Zimbabwe.
abstract: To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe.
authors.forename: John Z
authors.initials: JZ
authors.lastname: Metcalfe
authors.forename: Salome
authors.initials: S
authors.lastname: Makumbirofa
authors.forename: Beauty
authors.initials: B
authors.lastname: Makamure
authors.forename: Charles
authors.initials: C
authors.lastname: Sandy
authors.forename: Wilbert
authors.initials: W
authors.lastname: Bara
authors.forename: Stanley
authors.initials: S
authors.lastname: Mungofa
authors.forename: Philip C
authors.initials: PC
authors.lastname: Hopewell
authors.forename: Peter
authors.initials: P
authors.lastname: Mason
mesh_terms: D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D015995:Prevalence; D011446:Prospective Studies; D018088:Tuberculosis, Multidrug-Resistant / Q000453:epidemiology*; D015030:Zimbabwe / Q000453:epidemiology
keywords: HIV/TB; MDR TB; Mycobacterium tuberculosis; Zimbabwe; antimicrobial resistance; bacteria; drug-resistant tuberculosis; mycobacteria; retreatment tuberculosis; tuberculosis